Answers are grounded in this paper and cite their sources.
Managed access is one strategy that can be used by payers to resolve uncertainty for innovative technologies that present challenges for reimbursement and can also deliver earlier access to promising technologies for patients. However, participants cautioned that managed access is not a "silver bullet," and there is a need for greater clarity about the aims of managed access and how these should be prioritized in decision making. Discussions between key stakeholders involved in managed access identified challenges with implementing MAAs and these experiences should be used to inform future managed access policy.
No takes yet. Share an insight, caveat, or question.
Farmer et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: